Robert Lefkowitz
Director/Board Member at LEXICON PHARMACEUTICALS, INC.
Net worth: 82 219 $ as of 2024-05-30
Profile
Robert Joseph Lefkowitz is the founder of Xsira Pharmaceuticals, Inc. (1999) and Trevena, Inc. (2007).
He is also the founder of Septerna, Inc. Dr. Lefkowitz's current jobs include Independent Director at Lexicon Pharmaceuticals, Inc. (since 2001), Director at The Burroughs Wellcome Fund, and Member at National Academy of Sciences.
He is also a Professor at Duke University Medical Center (since 1973).
Dr. Lefkowitz's former jobs include Investigator at American Heart Association, Inc. (1973-1976), President at Association of American Physicians, and President at American Society for Clinical Investigation.
Dr. Lefkowitz received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1962 and his doctorate degree from Columbia University College of Physicians & Surgeons in 1966.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-12 | 48,364 ( 0.01% ) | 82 219 $ | 2024-05-30 |
Robert Lefkowitz active positions
Companies | Position | Start |
---|---|---|
LEXICON PHARMACEUTICALS, INC. | Director/Board Member | 2001-01-31 |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Duke University Medical Center | Corporate Officer/Principal | 1972-12-31 |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Director/Board Member | 2019-09-30 |
Former positions of Robert Lefkowitz
Companies | Position | End |
---|---|---|
Xsira Pharmaceuticals, Inc.
Xsira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xsira Pharmaceuticals, Inc. researches and develops pharmaceutical products. It also provides surgical and pain management drug products. The company was founded in 1999 and is headquartered in Morrisville, NC | Founder | 2009-09-16 |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 1975-12-31 |
Septerna, Inc.
Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Founder | - |
TREVENA, INC. | Founder | - |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | President | - |
Training of Robert Lefkowitz
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Columbia University College of Physicians & Surgeons | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
TREVENA, INC. | Health Technology |
Private companies | 7 |
---|---|
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Commercial Services |
Xsira Pharmaceuticals, Inc.
Xsira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xsira Pharmaceuticals, Inc. researches and develops pharmaceutical products. It also provides surgical and pain management drug products. The company was founded in 1999 and is headquartered in Morrisville, NC | Health Technology |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
Septerna, Inc.
Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Robert Lefkowitz